Review Article
The Role of 18F-FDG PET/CT and MRI in Assessing Pathological Complete Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer: A Systematic Review and Meta-Analysis
Figure 6
(a) SROC for NAC response prediction in primary breast cancer by 18F-FDG PET/CT. (b) SROC for NAC response prediction in primary breast cancer by MRI.
(a) 18FDG PET/CT |
(b) MRI |